Nyxoah is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Olivier Taelman, with a market cap of $123.1M.
Common questions about Nyxoah
Nyxoah is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $7.1M.
Nyxoah has approximately 147 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.